Medicare Enrolled
Dr. Vitor Pastorini Filho, M.D.
Medical Oncology · Fort Myers, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pastorini Filho from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pastorini Filho? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pastorini Filho
Dr. Vitor Pastorini Filho is a medical oncology in Fort Myers, FL, with 16 years in practice. Based on federal Medicare data, Dr. Pastorini Filho performed 113,490 Medicare services across 4,136 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pastorini Filho received a total of $16,554 from 81 pharmaceutical and/or device companies across 817 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pastorini Filho is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice▲ Top 23% volume in FL$ $16,554 industry payments
Medicare Practice Summary
Medicare Utilization ↗113,490
Medicare services
Top 23% in FL for medical oncology
4,136
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~7,093 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 54,060 | $0 | $4 |
| Azacitidine chemotherapy injection | 11,800 | $0 | $4 |
| Iron sucrose injection (Venofer) | 8,300 | $0 | $5 |
| Anti-nausea injection (aprepitant) | 7,410 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 7,080 | $19 | $51 |
| Paclitaxel chemotherapy injection | 4,165 | $0 | $2 |
| Immune globulin infusion (Gammagard) | 3,062 | $36 | $108 |
| Injection, eflapegrastim-xnst, 0.1 mg | 2,508 | $25 | $116 |
| Iron infusion (Monoferric) | 2,500 | $16 | $57 |
| Epoetin alfa injection (Procrit) for anemia | 2,330 | $6 | $23 |
| Blood draw (venipuncture) | 1,772 | $8 | $9 |
| Complete blood count (CBC) with differential | 1,722 | $8 | $29 |
| Dexamethasone injection (steroid) | 1,250 | $0 | $3 |
| Anti-nausea injection (Aloxi/palonosetron) | 790 | $1 | $28 |
| Office visit, established patient (30-39 min) | 595 | $94 | $339 |
| Drug injection, under skin or into muscle | 456 | $10 | $69 |
| Injection of additional new drug or substance into vein | 376 | $12 | $61 |
| Office visit, established patient (20-29 min) | 348 | $62 | $239 |
| Anti-nausea injection (ondansetron/Zofran) | 320 | $0 | $9 |
| Administration of chemotherapy into vein, 1 hour or less | 234 | $97 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 229 | $46 | $189 |
| Injection of drug or substance into vein | 157 | $27 | $156 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 145 | $1 | $6 |
| Injection, diphenhydramine hcl, up to 50 mg | 142 | $1 | $3 |
| New patient office visit (30-44 min) | 140 | $82 | $298 |
| Injection, carboplatin, 50 mg | 140 | $2 | $41 |
| Injection, zoledronic acid, 1 mg | 134 | $7 | $69 |
| Infusion, normal saline solution , 1000 cc | 105 | $2 | $7 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 94 | $15 | $56 |
| Initial hospital admission, high complexity | 88 | $136 | $556 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 79 | $55 | $206 |
| Infusion into a vein for hydration, 31-60 minutes | 78 | $25 | $156 |
| Administration of chemotherapy into vein, each additional hour | 76 | $20 | $79 |
| Red blood count automated, with additional calculations | 74 | $5 | $20 |
| Administration of additional new drug or substance into vein, 1 hour or less | 71 | $49 | $178 |
| Hospital follow-up visit, moderate complexity | 62 | $63 | $197 |
| Hospital follow-up visit, low complexity | 61 | $38 | $109 |
| Infusion into a vein for hydration, each additional hour | 59 | $10 | $42 |
| New patient office visit (45-59 min) | 58 | $131 | $453 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 58 | $17 | $59 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 56 | $21 | $84 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 46 | $3 | $11 |
| Automated urinalysis | 43 | $2 | $8 |
| New patient office visit, complex (60-74 min) | 38 | $150 | $585 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 36 | $24 | $89 |
| Red blood count, automated test | 35 | $4 | $10 |
| Office visit, established patient, complex (40-54 min) | 31 | $140 | $474 |
| Initial hospital admission, moderate complexity | 23 | $100 | $377 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 22 | $1 | $7 |
| Drawing of blood for a medical problem | 21 | $61 | $277 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 11 | $125 | $467 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
53.1% high complexity
42.3% medium
4.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,554
Total received (2018-2024)
Avg $2,365/year across 7 years
Top 30% in FL for medical oncology
81
Companies
817
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,670 (88.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,883 (11.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,806
2023$3,241
2022$2,712
2021$2,506
2020$102
2019$1,609
2018$2,576
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
G1 Therapeutics, Inc.
$1,558
Novartis Pharmaceuticals Corporation
$1,214
Janssen Biotech, Inc.
$988
AstraZeneca Pharmaceuticals LP
$856
E.R. Squibb & Sons, L.L.C.
$796
GENZYME CORPORATION
$758
Celgene Corporation
$717
PFIZER INC.
$698
Genentech USA, Inc.
$633
Takeda Pharmaceuticals U.S.A., Inc.
$551
Merck Sharp & Dohme LLC
$550
Merck Sharp & Dohme Corporation
$504
Incyte Corporation
$491
Seagen Inc.
$438
Eisai Inc.
$389
Amgen Inc.
$352
Lilly USA, LLC
$345
Daiichi Sankyo Inc.
$322
Gilead Sciences, Inc.
$261
Regeneron Healthcare Solutions, Inc.
$237
JAZZ PHARMACEUTICALS INC.
$233
EISAI INC.
$196
Astellas Pharma US Inc
$185
ABBVIE INC.
$183
Alexion Pharmaceuticals, Inc.
$178
Pharmacyclics LLC, An AbbVie Company
$160
Octapharma USA, Inc.
$153
ARRAY BIOPHARMA INC
$144
GlaxoSmithKline, LLC.
$143
Bayer Healthcare Pharmaceuticals Inc.
$130
Rigel Pharmaceuticals, Inc.
$123
Karyopharm Therapeutics Inc.
$114
Clovis Oncology, Inc.
$105
Janssen Pharmaceuticals, Inc
$103
Kite Pharma, Inc.
$102
Boehringer Ingelheim Pharmaceuticals, Inc.
$95
MorphoSys, US Inc.
$83
Exelixis Inc.
$83
Ipsen Biopharmaceuticals, Inc
$82
Stemline Therapeutics Inc.
$78
Lexicon Pharmaceuticals, Inc.
$78
Pharmacosmos Therapeutics Inc.
$72
Bayer HealthCare Pharmaceuticals Inc.
$68
PharmaEssentia USA Corporation
$64
Mirati Therapeutics, Inc.
$53
SERVIER PHARMACEUTICALS LLC
$52
Deciphera Pharmaceuticals Inc.
$52
AVEO Pharmaceuticals, Inc.
$51
Adaptive Biotechnologies Corporation
$48
TESARO, Inc.
$44
BeiGene USA, Inc.
$38
TAIHO ONCOLOGY, INC.
$38
Menarini Silicon Biosystems, Inc.
$38
Genmab U.S., Inc.
$34
PUMA BIOTECHNOLOGY, INC.
$31
CTI BioPharma Corp.
$29
EMD Serono, Inc.
$28
Heron Therapeutics, Inc.
$27
TG THERAPEUTICS, INC.
$27
MEDIVATION FIELD SOLUTIONS LLC
$27
TerSera Therapeutics LLC
$26
Kyowa Kirin, Inc.
$21
Agios Pharmaceuticals, Inc.
$20
SOBI, INC
$19
CSL Behring
$19
Apellis Pharmaceuticals, Inc.
$18
Novocure Inc.
$16
Verastem, Inc.
$15
EUSA Pharma (US) LLC
$15
Array BioPharma Inc.
$15
Dova Pharmaceuticals
$15
Sobi, Inc
$14
Global Blood Therapeutics, Inc.
$14
Taiho Oncology, Inc.
$14
Foundation Medicine, Inc.
$13
Alnylam Pharmaceuticals Inc.
$13
Pharmacyclics LLC, an AbbVie Company
$13
Seattle Genetics, Inc.
$12
AbbVie Inc.
$12
Blueprint Medicines Corporation
$12
GE HEALTHCARE
$10
Top 3 companies account for 22.7% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Avastin · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · Braftovi · CALQUENCE · CERDELGA · CHANTIX · CINVANTI · COSELA · CREON · CYRAMZA · Cabometyx · Cellsearch · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · EXKIVITY · Empaveli · Enhertu · Epkinly · Erivedge · Erleada · FASLODEX · FOTIVDA · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · GIVLAARI · Gazyva · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · IRESSA · Idelvion · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · Optune · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Perjeta · Polivy · Pomalyst · QINLOCK · REBLOZYL · RETACRIT · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · Stivarga · Sylvant · TABRECTA · TAFINLAR · TAGRISSO · TASIGNA · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · UKONIQ · ULTOMIRIS · VENCLEXTA · VERZENIO · VOTRIENT · VPRIV · Venclexta · Vonjo · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (89%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $15 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
15
Per 100K population
1.9
County median income
$73,099
Nearest hospital
GULF COAST MEDICAL CENTER LEE HEALTH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Pastorini Filho is a mixed practice specialist, with above-average Medicare volume (top 23% in FL), and low-engagement industry engagement, with 16 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Pastorini Filho experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Pastorini Filho performed 54,060 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pastorini Filho receive payments from pharmaceutical companies?
Yes. Dr. Pastorini Filho received a total of $16,554 from 81 companies across 817 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pastorini Filho's costs compare to other medical oncologys in Fort Myers?
Dr. Pastorini Filho's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pastorini Filho) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Fort Myers
Browse medical oncologys in Fort Myers ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
G1 Therapeutics, Inc. Payments to Doctors
See all physicians who received payments from G1 Therapeutics, Inc..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology